Skip to main content

OPTIMIZACION DE PEPTIDOS NEUROPROTECTORES FRENTE AL ICTUS QUE ATENUAN LA INACTIVACION EN EXCITOTOXICIDAD DE LAS VIAS DE SUPERVIVENCIA DEL NMDAR Y TRKB

BFU2016-75973-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells

  • Galán-Ganga, Marcos
  • Río, R. del
  • Jiménez-Moreno, Natalia
  • Díaz-Guerra, Margarita
  • Lastres-Becker, Isabel
Nuclear factor erythroid 2-related factor 2 (NRF2) is a pleiotropic transcription factor that has neuroprotective and anti-inflammatory effects, regulating more than 250 genes. As NRF2, cannabinoid receptor type 2 (CB2) is also implicated in the preservation of neurons against glia-driven inflammation. To this concern, little is known about the regulation pathways implicated in CB2 receptor expression. In this study, we analyze whether NRF2 could modulate the transcription of CB2 in neuronal and microglial cells. Bioinformatics analysis revealed an antioxidant response element in the promoter sequence of the CB2 receptor gene. Further analysis by chemical and genetic manipulations of this transcription factor demonstrated that NRF2 is not able to modulate the expression of CB2 in neurons. On the other hand, at the level of microglia, the expression of CB2 is NRF2-dependent. These results are related to the differential levels of expression of both genes regarding the brain cell type. Since modulation of CB2 receptor signaling may represent a promising therapeutic target with minimal psychotropic effects that can be used to modulate endocannabinoid-based therapeutic approaches and to reduce neurodegeneration, our findings will contribute to disclose the potential of CB2 as a novel target for treating different pathologies., This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants Refs. SAF2016-76520-R to ILB and BFU2016-75973-R to MDG).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Excitotoxic targeting of Kidins220 to the Golgi apparatus precedes calpain cleavage of Rap1-activation complexes

  • López-Menéndez, Celia
  • Simón-García, Ana
  • Gamir-Morralla, Andrea
  • Pose-Utrilla, Julia
  • Luján, Rafael
  • Mochizuki, Naoki
  • Díaz-Guerra, Margarita
  • Iglesias, Teresa
© The Author(s) 2019., Excitotoxic neuronal death induced by high concentrations of glutamate is a pathological event common to multiple acute or chronic neurodegenerative diseases. Excitotoxicity is mediated through overactivation of the N-Methyl-D-aspartate type of ionotropic glutamate receptors (NMDARs). Physiological stimulation of NMDARs triggers their endocytosis from the neuronal surface, inducing synaptic activity and survival. However almost nothing is known about the internalization of overactivated NMDARs and their interacting proteins, and how this endocytic process is connected with neuronal death has been poorly explored. Kinase D-interacting substrate of 220 kDa (Kidins220), also known as ankyrin repeat-rich membrane spanning (ARMS), is a component of NMDAR complexes essential for neuronal viability by the control of ERK activation. Here we have investigated Kidins220 endocytosis induced by NMDAR overstimulation and the participation of this internalization step in the molecular mechanisms of excitotoxicity. We show that excitotoxicity induces Kidins220 and GluN1 traffic to the Golgi apparatus (GA) before Kidins220 is degraded by the protease calpain. We also find that excitotoxicity triggers an early activation of Rap1-GTPase followed by its inactivation. Kidins220 excitotoxic endocytosis and subsequent calpain-mediated downregulation governs this late inactivation of Rap1 that is associated to decreases in ERK activity preceding neuronal death. Furthermore, we identify the molecular mechanisms involved in the excitotoxic shutoff of Kidins220/Rap1/ERK prosurvival cascade that depends on calpain processing of Rap1-activation complexes. Our data fit in a model where Kidins220 targeting to the GA during early excitotoxicity would facilitate Rap1 activation and subsequent stimulation of ERK. At later times, activation of Golgi-associated calpain, would promote the degradation of GA-targeted Kidins220 and two additional components of the specific Rap1 activation complex, PDZ-GEF1, and S-SCAM. In this way, late excitotoxicity would turn off Rap1/ERK cascade and compromise neuronal survival., This work was funded by grants SAF2014-52737-P and SAF2017-88885-R to T.I., BFU2016-75973-R to M.D.-G and BFU2015-63769-R to R.L. (Spanish Ministry ofScience, Innovation and Universities—MICIU, Spain). It was also supported by grant SBPLY/17/180501/000229 from Junta de Comunidades de Castilla-La Mancha to R.L. Additional funding to T.I. was received by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) as well as by grant S2017/BMD3700 (NEUROMETAB-CM) from Comunidad de Madrid co-financed with the Structural Funds of the European Union (FEDER). A.G.-M. was funded by contracts from CIBERNED. Contracts to A.S.-G and J.P.U were funded by grants S2017/BMD-3700 (NEUROMETAB-CM) and SAF2017-88885-R, respectively. The cost of this publication has been paid in part by FEDER funds.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prevention of excitotoxicity-induced processing of BDNF receptor TrkB-FL leads to stroke neuroprotection

  • Tejeda, Gonzalo S.
  • Esteban‐Ortega, Gema M.
  • San Antonio, Esther
  • Gómez Vidaurre, Óscar
  • Díaz-Guerra, Margarita
© 2019 The Authors., Neuroprotective strategies aimed to pharmacologically treat stroke, a prominent cause of death, disability, and dementia, have remained elusive. A promising approach is restriction of excitotoxic neuronal death in the infarct penumbra through enhancement of survival pathways initiated by brain‐derived neurotrophic factor (BDNF). However, boosting of neurotrophic signaling after ischemia is challenged by downregulation of BDNF high‐affinity receptor, full‐length tropomyosin‐related kinase B (TrkB‐FL), due to calpain‐degradation, and, secondarily, regulated intramembrane proteolysis. Here, we have designed a blood–brain barrier (BBB) permeable peptide containing TrkB‐FL sequences (TFL457) which prevents receptor disappearance from the neuronal surface, early induced after excitotoxicity. In this way, TFL457 interferes TrkB‐FL cleavage by both proteolytic systems and increases neuronal viability via a PLCγ‐dependent mechanism. By preserving downstream CREB and MEF2 promoter activities, TFL457 initiates a feedback mechanism favoring increased levels in excitotoxic neurons of critical prosurvival mRNAs and proteins. This neuroprotective peptide could be highly relevant for stroke therapy since, in a mouse ischemia model, it counteracts TrkB‐FL downregulation in the infarcted brain, efficiently decreases infarct size, and improves neurological outcome., We acknowledge funding from Ministerio de Economía y Competitividad (BFU2013-43808-R and BFU2016-75973-R). The cost of publication has been paid in part by FEDER funds. Contracts were funded associated with projects BFU2013-43808-R (G.S.T and G.M.E-O) and BFU2016-75973-R (G.M.E-O and E.SA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotection

  • Díaz-Guerra, Margarita
Decreased neuronal survival-signaling and brain damage: Stroke is a leading cause of death worldwide, the major cause of adult disability and second of dementia. In spite of the social and economic importance of this disorder, and after intense research, no effective drugs have yet reached the clinic. Blood reperfusion with the thrombolytic agent tissue plasminogen activator remains the only pharmacologic treatment currently available for ischemic stroke, the major type of brain infarction (> 85% of total cases)., This work was supported by BFU2016-75973-R (MINECO/AEI/FEDER, EU).